StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
45
This year
3
Publishing Date
2024 - 03 - 29
1
2024 - 02 - 22
1
2024 - 02 - 12
1
2023 - 12 - 22
1
2023 - 12 - 08
1
2023 - 11 - 17
1
2023 - 10 - 25
1
2023 - 09 - 09
1
2023 - 05 - 31
1
2023 - 03 - 06
1
2023 - 02 - 02
1
2023 - 01 - 19
1
2023 - 01 - 16
1
2022 - 12 - 30
1
2022 - 12 - 28
1
2022 - 11 - 10
1
2022 - 11 - 03
1
2022 - 09 - 06
1
2022 - 08 - 19
1
2022 - 08 - 12
1
2022 - 08 - 11
1
2022 - 07 - 04
1
2022 - 04 - 26
1
2022 - 04 - 21
1
2022 - 04 - 13
1
2022 - 03 - 16
1
2022 - 03 - 08
1
2021 - 08 - 04
1
2021 - 07 - 23
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 17
1
2021 - 06 - 09
1
2021 - 06 - 04
1
2021 - 05 - 24
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 12
1
2021 - 03 - 25
1
2021 - 03 - 19
2
2021 - 03 - 16
1
2021 - 03 - 11
1
Sector
Communications
1
Health technology
45
Manufacturing
4
N/a
3
Process industries
2
Tags
Antiviral
5
Approval
1
Cancer
1
Car-t
1
Covid-19
2
Diagnostics
1
Disease
2
Drug
4
Ema
2
Funding
1
Global
12
Growing
2
Growth
5
Health
1
Hepatitis
1
Hiv
4
Immunotherapy
1
Impact
2
Iot
1
Leukemia
1
Liver
1
Market
22
N/a
44
Patent
1
People
1
Pharma
1
Pharmaceuticals
1
Potential
1
Reach
3
Report
11
Repurposed
1
Research
6
Study
1
T-cell
1
Technology
1
Therapeutics
7
Therapy
5
Treatment
3
Entities
Aadi biosciences inc
3
Abbott laboratories
12
Abbvie inc.
41
Adaptimmune therapeutics plc
3
Allovir, inc.
3
Alnylam pharmaceuticals, inc.
6
Amgen inc.
35
Arcellx, inc.
7
Arcus biosciences, inc.
3
Assembly biosciences, inc.
6
Astellas pharma inc
3
Astrazeneca plc
10
Baxter international inc.
3
Biocryst pharmaceuticals, inc.
13
Biogen inc.
6
Biomarin pharmaceutical inc.
4
Biontech se
3
Bluebird bio, inc.
4
Bristol-myers squibb company
45
Calliditas therapeutics ab
3
Crispr therapeutics ag
3
Cymabay therapeutics inc.
3
Editas medicine, inc.
3
Eli lilly and company
35
Exelixis, inc.
3
Galapagos nv
20
Genmab a/s
4
Gilead sciences, inc.
500
Glaxosmithkline plc
24
Hookipa pharma inc.
16
Humanigen, inc.
3
Immunogen, inc.
4
Intellia therapeutics, inc.
3
Johnson & johnson
43
Jounce therapeutics, inc.
25
Macrogenics, inc.
5
Merck & company, inc.
5
Morphosys ag
4
Novartis ag
28
Novo nordisk a/s
10
Nrx pharmaceuticals inc
3
Nurix therapeutics, inc.
4
Omeros corporation
14
Orange
8
Otonomy, inc.
13
Pfizer, inc.
27
Regeneron pharmaceuticals, inc.
11
Sangamo therapeutics, inc.
4
Sanofi
64
Sarepta therapeutics, inc.
4
Sorrento therapeutics, inc.
4
Takeda pharmaceutical company limited
15
Teva pharmaceutical industries ltd
10
Thermo fisher scientific inc
4
Vertex pharmaceuticals incorporated
6
Veru inc.
4
Viatris inc.
5
Vir biotechnology, inc.
6
Xeris pharmaceuticals, inc.
11
Xilio therapeutics inc
4
Symbols
ABBV
88
ABT
26
ADCT
13
ADXS
8
AGIO
12
ALB
8
ALNY
11
ALPMF
11
ALPMY
11
AMGN
86
AVEO
19
AYLA
12
AZN
61
AZNCF
53
BCRX
13
BGNE
12
BHC
10
BIIB
11
BLUE
8
BMY
662
BOLT
7
BPMC
19
BSX
6
CLVS
20
EPZM
18
EXEL
29
GILD
45
GLAXF
50
GMAB
6
GNMSF
6
GSK
67
ILMN
10
INCY
24
INTS
12
JNJ
91
KPTI
19
LLY
106
MRTX
10
NKTR
7
NVO
7
NVS
103
NVSEF
82
OMER
13
OTIC
13
PFE
61
REGN
30
RIGL
11
SNY
119
SNYNF
70
TAK
43
TEVA
8
TEVJF
37
TPTX
7
TSVT
11
UCBJF
8
UCBJY
8
VSTM
11
VTRS
15
XERS
10
YMAB
18
Exchanges
Nasdaq
45
Nyse
45
Crawled Date
2024 - 03 - 29
1
2024 - 02 - 22
1
2024 - 02 - 12
1
2023 - 12 - 22
1
2023 - 12 - 08
1
2023 - 11 - 17
1
2023 - 10 - 25
1
2023 - 09 - 09
1
2023 - 06 - 01
1
2023 - 03 - 06
1
2023 - 02 - 02
1
2023 - 01 - 19
1
2023 - 01 - 16
1
2022 - 12 - 30
1
2022 - 12 - 28
1
2022 - 11 - 10
1
2022 - 11 - 03
1
2022 - 09 - 06
1
2022 - 08 - 19
1
2022 - 08 - 12
1
2022 - 08 - 11
1
2022 - 07 - 04
1
2022 - 04 - 26
1
2022 - 04 - 21
1
2022 - 04 - 13
1
2022 - 03 - 16
1
2022 - 03 - 08
1
2021 - 08 - 04
1
2021 - 07 - 27
1
2021 - 06 - 24
1
2021 - 06 - 22
1
2021 - 06 - 17
1
2021 - 06 - 09
1
2021 - 06 - 04
1
2021 - 05 - 25
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 13
1
2021 - 03 - 25
1
2021 - 03 - 19
2
2021 - 03 - 16
1
2021 - 03 - 11
1
Crawled Time
00:00
5
04:20
1
08:00
1
10:51
1
11:00
3
12:00
1
12:34
1
13:00
1
13:07
1
13:17
1
13:20
1
13:27
1
14:00
1
14:03
1
14:20
1
14:30
1
15:00
2
15:49
1
16:00
3
17:00
3
17:43
1
18:00
3
18:32
1
19:00
2
19:47
1
20:00
4
21:00
1
22:00
1
Source
www.biospace.com
1
www.fda.gov
14
www.prnewswire.com
30
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Bristol-myers squibb company
symbols :
Gild
save search
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published:
2024-02-22
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.97%
|
O:
0.37%
H:
0.58%
C:
0.58%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-9.46%
|
O:
0.89%
H:
0.4%
C:
0.17%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
-2.45%
|
O:
0.57%
H:
0.47%
C:
-0.58%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-5.9%
|
O:
0.14%
H:
1.01%
C:
0.51%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
-6.56%
|
O:
0.29%
H:
0.93%
C:
0.47%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-5.02%
|
O:
0.97%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-8.08%
|
O:
0.65%
H:
1.35%
C:
0.41%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-7.1%
|
O:
0.47%
H:
2.0%
C:
0.93%
pharmaceuticals
market
Liver Disease Therapeutics Competitive Landscape and Market Forecasts to 2028
Published:
2024-02-12
(Crawled : 20:00)
- prnewswire.com
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-13.68%
|
O:
0.37%
H:
0.74%
C:
0.28%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-2.91%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
-4.57%
|
O:
0.8%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-1.49%
|
O:
-0.06%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-10.14%
|
O:
0.32%
H:
0.11%
C:
-1.55%
ALNY
|
News
|
$145.045
-0.19%
-0.19%
400K
|
Health Technology
|
-14.28%
|
O:
-2.63%
H:
0.98%
C:
-1.75%
liver
disease
therapeutics
market
Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published:
2023-12-22
(Crawled : 17:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-3.25%
|
O:
3.66%
H:
0.0%
C:
-0.12%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
3.68%
|
O:
3.33%
H:
0.0%
C:
-2.93%
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
20.34%
|
O:
-0.31%
H:
0.39%
C:
-0.44%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-5.58%
|
O:
1.09%
H:
0.0%
C:
0.0%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
31.25%
|
O:
0.18%
H:
0.5%
C:
-0.46%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-5.77%
|
O:
-0.78%
H:
5.15%
C:
2.81%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
8.24%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-6.61%
|
O:
1.03%
H:
0.0%
C:
0.0%
REGN
|
$893.66
-0.84%
-0.84%
450K
|
Health Technology
|
7.04%
|
O:
0.52%
H:
0.58%
C:
0.05%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-15.24%
|
O:
0.34%
H:
1.02%
C:
0.59%
BIIB
|
$190.55
-0.84%
-0.84%
1.5M
|
Health Technology
|
-23.13%
|
O:
0.57%
H:
1.36%
C:
1.04%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
2.96%
|
O:
1.06%
H:
0.18%
C:
-1.06%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-5.15%
|
O:
0.24%
H:
2.03%
C:
1.49%
patent
report
global
market
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published:
2023-12-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-22.28%
|
O:
-2.79%
H:
0.62%
C:
0.62%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
2.34%
|
O:
2.06%
H:
0.82%
C:
0.82%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-3.34%
|
O:
-1.29%
H:
0.4%
C:
0.4%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-23.82%
|
O:
-2.2%
H:
0.0%
C:
-0.27%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-6.61%
|
O:
-0.64%
H:
0.5%
C:
0.5%
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
28.63%
|
O:
-0.42%
H:
0.67%
C:
0.25%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-2.97%
|
O:
0.19%
H:
0.35%
C:
0.2%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-7.07%
|
O:
-0.18%
H:
0.0%
C:
0.0%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
27.99%
|
O:
0.43%
H:
0.0%
C:
0.0%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-3.71%
|
O:
0.2%
H:
0.55%
C:
0.1%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
11.75%
|
O:
0.3%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-0.46%
|
O:
1.07%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-14.29%
|
O:
0.08%
H:
1.45%
C:
1.17%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-2.35%
|
O:
-0.05%
H:
0.3%
C:
-0.76%
reach
market
HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published:
2023-11-17
(Crawled : 16:00)
- prnewswire.com
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-3.05%
|
O:
0.78%
H:
0.0%
C:
0.0%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-5.0%
|
O:
0.69%
H:
0.06%
C:
-0.68%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
19.44%
|
O:
0.01%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-10.23%
|
O:
0.5%
H:
0.82%
C:
0.75%
reach
research
hiv
market
Global HIV Diagnostics Market Predicted to Reach $1.5 Billion by 2030, with a CAGR of 5.5%
Published:
2023-10-25
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-13.93%
|
O:
-0.18%
H:
1.34%
C:
1.05%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-14.4%
|
O:
-0.31%
H:
0.89%
C:
0.62%
reach
global
hiv
diagnostics
market
Oral Antiviral Market Report 2023: Demand for Novel Therapeutics Boosts Opportunities
Published:
2023-09-09
(Crawled : 04:20)
- prnewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
Email alert
Add to watchlist
report
antiviral
therapeutics
market
Global HIV Treatment Market Report 2023: Advances in Gene Therapy Present Significant Opportunities for Sector Growth
Published:
2023-05-31
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
21.03%
|
O:
-0.24%
H:
2.1%
C:
2.1%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
21.53%
|
O:
0.0%
H:
0.66%
C:
0.33%
TEVA
|
$12.78
-3.03%
-0.24%
9M
|
Health Technology
|
83.06%
|
O:
0.42%
H:
0.83%
C:
-0.41%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-6.52%
|
O:
-0.34%
H:
0.32%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
17.86%
|
O:
-0.24%
H:
1.43%
C:
0.84%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-25.05%
|
O:
0.03%
H:
0.41%
C:
0.34%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
19.72%
|
O:
-1.96%
H:
0.0%
C:
-1.35%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
4.31%
|
O:
-0.09%
H:
0.97%
C:
0.89%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-13.05%
|
O:
0.78%
H:
0.0%
C:
-1.72%
report
treatment
global
hiv
therapy
growth
market
Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published:
2023-03-06
(Crawled : 20:00)
- prnewswire.com
CMXHF
|
$172.54
-19.21%
50
|
n/a
|
-10.86%
|
O:
-0.86%
H:
0.33%
C:
0.33%
CSLLY
|
$87.96
3.3%
45K
|
n/a
|
-11.33%
|
O:
-0.02%
H:
0.54%
C:
-1.7%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
3.92%
|
O:
-2.57%
H:
1.62%
C:
1.62%
TMO
|
News
|
$541.52
-1.05%
0.61%
2.1M
|
Health Technology
|
-4.57%
|
O:
0.41%
H:
0.39%
C:
-2.14%
TEVA
|
$12.78
-3.03%
-0.24%
9M
|
Health Technology
|
33.0%
|
O:
-1.21%
H:
0.43%
C:
-3.58%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-15.92%
|
O:
0.83%
H:
0.06%
C:
-1.2%
PRGO
|
$29.94
-0.33%
0.0%
970K
|
Health Technology
|
-18.72%
|
O:
0.76%
H:
1.91%
C:
1.26%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
14.95%
|
O:
0.32%
H:
0.17%
C:
-1.53%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
135.38%
|
O:
0.01%
H:
0.42%
C:
-2.62%
CTLT
|
$55.8
-0.29%
0.0%
1M
|
Health Technology
|
-21.81%
|
O:
0.11%
H:
0.53%
C:
-5.05%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-29.9%
|
O:
0.41%
H:
0.04%
C:
-1.71%
ALB
|
News
|
$111.8
-2.26%
0.63%
2.2M
|
Process Industries
|
-55.43%
|
O:
-0.95%
H:
1.02%
C:
-2.19%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
6.36%
|
O:
0.19%
H:
0.06%
C:
-1.7%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-4.65%
|
O:
0.65%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-17.52%
|
O:
0.23%
H:
0.0%
C:
-1.25%
BIIB
|
$190.55
-0.84%
-0.84%
1.5M
|
Health Technology
|
-27.79%
|
O:
0.28%
H:
0.0%
C:
-2.26%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
5.74%
|
O:
0.9%
H:
0.28%
C:
-1.3%
global
report
market
The Global Antiviral Drugs Market to Exhibit Growth at a Paltry CAGR of ~4% by 2027 | DelveInsight
Published:
2023-02-02
(Crawled : 16:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
28.31%
|
O:
-1.71%
H:
0.0%
C:
0.0%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
-9.3%
|
O:
-0.16%
H:
0.08%
C:
-0.41%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
5.5%
|
O:
-1.87%
H:
0.01%
C:
-0.55%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-12.11%
|
O:
-1.16%
H:
1.98%
C:
1.56%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-32.19%
|
O:
-1.28%
H:
3.64%
C:
3.48%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
12.66%
|
O:
-0.46%
H:
0.0%
C:
-0.75%
VIR
|
$7.96
-3.52%
-3.64%
880K
|
Health Technology
|
-71.71%
|
O:
0.62%
H:
2.22%
C:
1.94%
TNXP
|
$0.1549
-2.82%
-2.91%
1.4M
|
Health Technology
|
-97.81%
|
O:
0.85%
H:
5.08%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-6.26%
|
O:
-1.44%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-20.36%
|
O:
-1.95%
H:
0.16%
C:
-1.18%
global
antiviral
growth
market
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published:
2023-01-19
(Crawled : 17:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
14.14%
|
O:
0.69%
H:
0.0%
C:
-1.52%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-4.71%
|
O:
1.26%
H:
1.19%
C:
1.19%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-18.53%
|
O:
-0.31%
H:
1.15%
C:
0.68%
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
-10.9%
|
O:
0.13%
H:
0.65%
C:
0.51%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
1.0%
|
O:
-0.1%
H:
0.31%
C:
0.17%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-14.61%
|
O:
-0.43%
H:
1.33%
C:
0.3%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
12.53%
|
O:
0.17%
H:
1.36%
C:
1.02%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
113.28%
|
O:
0.1%
H:
0.97%
C:
-0.37%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-33.05%
|
O:
0.29%
H:
2.1%
C:
1.94%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
10.7%
|
O:
-0.17%
H:
1.07%
C:
-0.16%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-8.54%
|
O:
-0.92%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-20.11%
|
O:
0.51%
H:
0.49%
C:
-0.65%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
0.21%
|
O:
-0.9%
H:
0.58%
C:
0.01%
global
report
growth
market
Global Antiviral Therapeutics Market 2022 to 2027 - Rising Prevalence of Viral Diseases like HIV and Hepatitis Drives Growth
Published:
2023-01-16
(Crawled : 20:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-7.27%
|
O:
-0.2%
H:
0.0%
C:
0.0%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-46.88%
|
O:
-2.74%
H:
0.43%
C:
-0.99%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-16.42%
|
O:
0.33%
H:
0.33%
C:
-0.94%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-33.39%
|
O:
0.83%
H:
0.52%
C:
-1.09%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
-6.26%
|
O:
-0.01%
H:
0.69%
C:
-0.1%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-7.65%
|
O:
1.1%
H:
0.22%
C:
0.02%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-22.45%
|
O:
-0.26%
H:
0.37%
C:
-0.74%
COCP
|
$1.43
-1.39%
5.1K
|
Health Technology
|
-29.91%
|
O:
0.47%
H:
11.16%
C:
7.91%
hepatitis
global
antiviral
hiv
therapeutics
growth
market
Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published:
2022-12-30
(Crawled : 15:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-3.69%
|
O:
0.77%
H:
0.0%
C:
-0.74%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
0.14%
|
O:
1.08%
H:
0.0%
C:
-0.25%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-50.48%
|
O:
-0.08%
H:
0.21%
C:
-0.1%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
1.62%
|
O:
-0.01%
H:
0.08%
C:
-0.95%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-18.37%
|
O:
-0.04%
H:
0.16%
C:
-0.47%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-33.01%
|
O:
0.04%
H:
0.21%
C:
-0.25%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-6.26%
|
O:
-0.39%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-21.53%
|
O:
0.08%
H:
0.66%
C:
0.61%
EXEL
|
$22.47
-1.75%
-1.78%
2.6M
|
Health Technology
|
47.03%
|
O:
-0.32%
H:
2.91%
C:
2.75%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
0.24%
|
O:
-0.46%
H:
0.38%
C:
0.01%
global
disease
report
therapeutics
cancer
market
Hagens Berman Sobol Shapiro LLP, Hilliard & Shadowen LLP, and Durie Tangri LLP Announce a Class Action Involving Antiretroviral Drugs
Published:
2022-12-28
(Crawled : 21:00)
- prnewswire.com
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-17.95%
|
O:
0.5%
H:
0.42%
C:
0.01%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-32.91%
|
O:
0.43%
H:
0.47%
C:
-0.28%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-20.89%
|
O:
0.4%
H:
0.78%
C:
0.41%
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published:
2022-11-10
(Crawled : 17:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
29.9%
|
O:
-0.06%
H:
0.0%
C:
0.0%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
12.29%
|
O:
6.22%
H:
3.13%
C:
-0.56%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
12.19%
|
O:
2.81%
H:
0.43%
C:
-0.2%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-16.77%
|
O:
0.18%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
22.15%
|
O:
2.59%
H:
0.72%
C:
0.63%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-39.46%
|
O:
1.22%
H:
0.01%
C:
-1.7%
IOVA
M
|
$11.72
-0.68%
-0.68%
3.6M
|
Health Technology
|
50.51%
|
O:
6.12%
H:
4.99%
C:
4.21%
INO
3 d
|
$10.22
-7.68%
-8.32%
400K
|
Health Technology
|
367.89%
|
O:
5.5%
H:
4.35%
C:
3.48%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-18.73%
|
O:
1.43%
H:
0.36%
C:
-1.08%
ATRA
|
$0.6917
-3.25%
-3.35%
830K
|
Health Technology
|
-82.43%
|
O:
2.58%
H:
23.12%
C:
20.85%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
11.82%
|
O:
7.08%
H:
0.84%
C:
-0.43%
ADAP
|
$0.8984
-8.98%
-9.86%
3.3M
|
Health Technology
|
-50.95%
|
O:
0.0%
H:
7.14%
C:
5.71%
covid-19
research
global
immunotherapy
report
impact
technology
market
Pediatric Health Market Research Report by Type, Therapeutics, Treatment, Treatment Type, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published:
2022-11-03
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
6.86%
|
O:
-0.02%
H:
0.43%
C:
0.43%
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
11.87%
|
O:
-1.02%
H:
2.67%
C:
0.18%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
41.88%
|
O:
2.28%
H:
0.0%
C:
0.0%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
14.99%
|
O:
0.83%
H:
1.33%
C:
-0.51%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
15.8%
|
O:
1.13%
H:
0.63%
C:
0.53%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
107.58%
|
O:
0.97%
H:
0.18%
C:
-2.13%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-38.46%
|
O:
0.42%
H:
0.59%
C:
-0.04%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
10.32%
|
O:
1.43%
H:
0.41%
C:
0.25%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
7.26%
|
O:
2.05%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-15.81%
|
O:
-0.4%
H:
2.75%
C:
1.52%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
13.91%
|
O:
0.72%
H:
1.29%
C:
1.04%
covid-19
treatment
research
global
report
impact
health
market
Disease-Modifying Antirheumatic Drug (DMARD) Market to Surpass US$ 27,167.8 Million by 2030 - Coherent Market Insights
Published:
2022-09-06
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
17.12%
|
O:
-3.02%
H:
0.0%
C:
0.0%
UCBJY
|
$64.07
-4.38%
72K
|
Manufacturing
|
86.52%
|
O:
0.73%
H:
2.28%
C:
1.72%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-11.61%
|
O:
-0.65%
H:
0.93%
C:
0.71%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-29.64%
|
O:
0.03%
H:
1.18%
C:
0.13%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
20.04%
|
O:
-0.03%
H:
1.08%
C:
0.84%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
14.25%
|
O:
0.49%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
5.54%
|
O:
0.44%
H:
2.03%
C:
1.76%
CPIX
|
$1.57
6.02%
1.4K
|
Health Technology
|
-29.41%
|
O:
-4.52%
H:
7.12%
C:
5.69%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
9.38%
|
O:
0.24%
H:
1.04%
C:
0.82%
drug
market
Red Biotechnology Market to Exceed US$ 609.6 Bn by 2031: TMR Study
Published:
2022-08-19
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
3.94%
|
O:
3.04%
H:
0.12%
C:
-2.22%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
-7.26%
|
O:
-2.05%
H:
0.29%
C:
0.07%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-47.67%
|
O:
0.54%
H:
1.24%
C:
0.63%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-34.86%
|
O:
0.01%
H:
2.09%
C:
1.58%
REGN
|
$893.66
-0.84%
-0.84%
450K
|
Health Technology
|
44.23%
|
O:
-0.62%
H:
0.57%
C:
-0.42%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
2.64%
|
O:
-0.25%
H:
1.19%
C:
0.49%
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
2.65%
|
O:
0.78%
H:
0.49%
C:
0.22%
study
market
Global Engineered T Cells Market Report 2022-2027: Immuno-Oncology Sector Increasing R&D Funding & Expanding Gene Therapy Marketspace Generating High-Potential Opportunities
Published:
2022-08-12
(Crawled : 14:20)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
34.17%
|
O:
1.51%
H:
0.0%
C:
0.0%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
8.76%
|
O:
-0.61%
H:
0.9%
C:
0.73%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-35.13%
|
O:
0.16%
H:
1.53%
C:
1.33%
DTIL
|
$10.77
-6.43%
-6.87%
71K
|
Health Technology
|
557.67%
|
O:
0.61%
H:
23.78%
C:
22.56%
PSTX
|
News
|
$2.005
-1.72%
-1.75%
520K
|
Health Technology
|
-50.24%
|
O:
-1.7%
H:
12.62%
C:
8.91%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
7.13%
|
O:
0.42%
H:
0.45%
C:
0.4%
CABA
|
$13.96
-7.86%
-8.52%
1.1M
|
Health Technology
|
1023.45%
|
O:
2.76%
H:
4.7%
C:
2.68%
BLCM
|
$0.0748
381.28%
6.1K
|
Health Technology
|
-94.73%
|
O:
3.58%
H:
1.99%
C:
-1.41%
ATNX
|
$0.2031
-7.78%
1.9M
|
Health Technology
|
-62.24%
|
O:
2.25%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
6.68%
|
O:
0.07%
H:
0.54%
C:
-0.05%
global
report
funding
therapy
market
← Previous
1
2
3
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.